ATE457733T1 - Lipid-a- und andere kohlenhydrat-liganden-analoga - Google Patents

Lipid-a- und andere kohlenhydrat-liganden-analoga

Info

Publication number
ATE457733T1
ATE457733T1 AT03726743T AT03726743T ATE457733T1 AT E457733 T1 ATE457733 T1 AT E457733T1 AT 03726743 T AT03726743 T AT 03726743T AT 03726743 T AT03726743 T AT 03726743T AT E457733 T1 ATE457733 T1 AT E457733T1
Authority
AT
Austria
Prior art keywords
lipid
analogs
useful
replacement
nature
Prior art date
Application number
AT03726743T
Other languages
English (en)
Inventor
Zi-Hua Jiang
R Koganty
Wladyslaw Budzynski
Original Assignee
Oncothyreon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncothyreon Inc filed Critical Oncothyreon Inc
Application granted granted Critical
Publication of ATE457733T1 publication Critical patent/ATE457733T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06Fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT03726743T 2002-05-09 2003-05-09 Lipid-a- und andere kohlenhydrat-liganden-analoga ATE457733T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37864502P 2002-05-09 2002-05-09
PCT/US2003/014633 WO2003094850A2 (en) 2002-05-09 2003-05-09 Lipid a and other carbohydrate ligand analogs

Publications (1)

Publication Number Publication Date
ATE457733T1 true ATE457733T1 (de) 2010-03-15

Family

ID=29420423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03726743T ATE457733T1 (de) 2002-05-09 2003-05-09 Lipid-a- und andere kohlenhydrat-liganden-analoga

Country Status (9)

Country Link
US (2) US7820627B2 (de)
EP (1) EP1549322B1 (de)
JP (1) JP5014573B2 (de)
AT (1) ATE457733T1 (de)
AU (1) AU2003228966C1 (de)
CA (1) CA2485253C (de)
DE (1) DE60331330D1 (de)
ES (1) ES2343788T3 (de)
WO (1) WO2003094850A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2441809C (en) 2001-03-27 2014-07-22 Biomira, Inc. Liposomal vaccines comprising dilipopeptides for modulating t1 and t2 immune responses
AU2003228966C1 (en) 2002-05-09 2010-05-13 Oncothyreon Inc. Lipid A and other carbohydrate ligand analogs
TW201204410A (en) 2004-04-01 2012-02-01 Oncothyreon Inc Mucinous glycoprotein (MUC-1) vaccine
TWI511738B (zh) 2005-06-28 2015-12-11 Oncothyreon Inc 以黏液性糖蛋白(muc-1)疫苗治療病人之方法
ATE524509T1 (de) 2005-07-18 2011-09-15 Nektar Therapeutics Verzweigte funktionalisierte polymere unter verwendung von verzweigten polyolen als kernen
ITMI20060530A1 (it) * 2006-03-22 2007-09-23 Univ Milano Bicocca Antinfiammatori a struttura monosaccaridica
WO2008021367A2 (en) 2006-08-11 2008-02-21 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
PT2484375T (pt) 2006-09-26 2018-07-09 Infectious Disease Res Inst Composição para vacina contendo adjuvante sintético
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
KR101012587B1 (ko) * 2007-06-04 2011-02-01 엘지전자 주식회사 디스플레이 장치
WO2009046314A2 (en) * 2007-10-04 2009-04-09 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
US9283184B2 (en) 2008-11-24 2016-03-15 Massachusetts Institute Of Technology Methods and compositions for localized agent delivery
HRP20161585T1 (hr) 2009-06-05 2016-12-30 Infectious Disease Research Institute Sintetski glukopiranozilni lipidi kao adjuvansi i cjepivni pripravci koji ih sadrže
CN102329335B (zh) * 2010-07-13 2014-01-22 哈尔滨工业大学 基于季戊四醇的复合脂质,制备方法及用途
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
MX2012010810A (es) * 2010-03-19 2013-02-07 Massachusetts Inst Technology Composiciones de vesícula de lípido y métodos de uso.
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
BR112013021779A2 (pt) 2011-02-24 2017-09-19 Oncothyreon Inc vacina de glicolipopeptídeo baseada em muc1 com adjuvante.
EP3632463A1 (de) 2011-04-08 2020-04-08 Immune Design Corp. Immunogene zusammensetzungen und verfahren zur verwendung der zusammensetzungen zur induzierung humoraler und zellulärer immunreaktionen
WO2013152277A2 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
WO2013151697A1 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
US9902985B2 (en) 2012-04-06 2018-02-27 President And Fellows Of Harvard College Chemoenzymatic methods for synthesizing moenomycin analogs
US9555099B2 (en) 2012-05-16 2017-01-31 Immune Design Corp. Vaccines for HSV-2
AU2014253791B2 (en) 2013-04-18 2019-05-02 Immune Design Corp. GLA monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
EP4043036A1 (de) 2013-09-27 2022-08-17 Massachusetts Institute of Technology Trägerfreie biologisch aktive proteinnanostrukturen
CN107531736B (zh) 2015-01-06 2022-04-15 免疫疫苗科技公司 脂质a模拟物、其制备方法和用途
US11034752B2 (en) 2015-08-12 2021-06-15 Massachusetts Institute Of Technology Cell surface coupling of nanoparticles
JP7185530B2 (ja) 2016-06-13 2022-12-07 トルク セラピューティクス, インコーポレイテッド 免疫細胞機能を促進するための方法および組成物
CA3074826A1 (en) 2017-09-05 2019-03-14 Torque Therapeutics, Inc. Therapeutic protein compositions and methods of making and using the same
US11458151B2 (en) 2018-02-12 2022-10-04 Inimmune Corporation Toll-like receptor ligands
JPWO2022255037A1 (de) * 2021-05-31 2022-12-08
CN114399151A (zh) * 2021-11-29 2022-04-26 阿里巴巴新加坡控股有限公司 运力订单分配方法、装置、可读程序产品及导航方法
CN116162115B (zh) * 2022-12-27 2025-09-26 华中师范大学 Toll样受体4免疫激动剂及其应用、抗病毒疫苗分子及其制备方法和应用
KR102827958B1 (ko) 2025-04-09 2025-07-03 주식회사 로우맵 피부흡수 촉진용 히알루론산 나노캡슐, 이의 제조방법 및 이를 포함한 화장료 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB614215A (en) * 1946-07-09 1948-12-10 Leslie Bradford Manufacture of polyureas
GB699080A (en) 1950-05-31 1953-10-28 Ici Ltd Production of new esters of ortho-phosphoric acid and salts thereof
US3930024A (en) * 1969-09-02 1975-12-30 Parke Davis & Co Pharmaceutical compositions and methods
DE3127503A1 (de) 1981-07-11 1983-02-17 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4464383A (en) * 1981-11-24 1984-08-07 Itaru Yamamoto Immunomodulator containing trithiazole pentamethine cyanine derivative
US4783402A (en) * 1983-04-11 1988-11-08 Meito Sangyo Kabushiki Kaisha Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique
GR860379B (en) * 1985-02-22 1986-06-11 Akzo Nv Novel disaccharide and trisaccharide derivatives of the lipid a type
WO1986005687A1 (en) 1985-04-03 1986-10-09 Wisconsin Alumni Research Foundation Method of preventing diseases caused by gram-negative endotoxin in mammals
JPS63139186A (ja) 1986-11-29 1988-06-10 Hidetoshi Tsuchida 三本鎖型リン脂質化合物およびその製造方法
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5041427A (en) * 1989-07-21 1991-08-20 Wisconsin Alumni Research Foundation Lipid A derivatives
JPH0655749B2 (ja) * 1989-09-20 1994-07-27 日本たばこ産業株式会社 リピッドa単糖類縁体
FR2702306B1 (fr) 1993-03-05 1995-04-14 Alcatel Nv Procédé d'auto-alignement d'un contact métallique sur un substrat de matériau semi-conducteur.
IT1264690B1 (it) * 1993-07-08 1996-10-04 Bracco Spa Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi
DE4408248A1 (de) * 1994-03-11 1995-09-14 Hoechst Ag Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
AU2247095A (en) 1994-04-12 1995-10-30 Biomira Inc. Cellular immune response-specific antigens and uses therefor
US6764840B2 (en) * 1997-05-08 2004-07-20 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6113918A (en) * 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
IT1295460B1 (it) 1997-10-02 1999-05-12 Borgotec Tecnologie Autom Spa Metodo per impilare pacchi di piastre di circuiti stampati e relativo dispositivo di carico e scarico di pacchi per una macchina utensile.
US6043390A (en) * 1998-04-03 2000-03-28 The Regents Of The University Of California Pentaerythritol lipid derivatives and nucleic-acid complexes
EP1097122B1 (de) * 1998-07-21 2004-09-22 Lonza A.G. Verfahren zur herstellung von aminen
US7491707B1 (en) 1999-11-15 2009-02-17 Biomira, Inc. Synthetic lipid-a-analogs and uses thereof
US6699846B2 (en) * 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
ES2164013B1 (es) 2000-04-14 2003-06-16 Consejo Superior Investigacion Glicosidos de n-acetil-6-o-(2,2-bis(hidroximetil)-3-hidroxipropil)-d-glucosamina, procedimiento de obtencion y uso en el tratamiento de tumores cerebrales.
AU2003203079B8 (en) * 2002-02-04 2009-01-15 Oncothyreon Inc. Immunostimulatory, covalently lipidated oligonucleotides
US20060069238A1 (en) 2002-04-15 2006-03-30 Biomira, Inc. Synthetic glyco-lipo-peptides as vaccines
AU2003228966C1 (en) 2002-05-09 2010-05-13 Oncothyreon Inc. Lipid A and other carbohydrate ligand analogs

Also Published As

Publication number Publication date
AU2003228966B2 (en) 2009-10-01
CA2485253A1 (en) 2003-11-20
US8097593B1 (en) 2012-01-17
ES2343788T3 (es) 2010-08-10
AU2003228966C1 (en) 2010-05-13
DE60331330D1 (de) 2010-04-01
EP1549322A2 (de) 2005-07-06
US7820627B2 (en) 2010-10-26
CA2485253C (en) 2012-07-10
WO2003094850A3 (en) 2004-07-29
WO2003094850A2 (en) 2003-11-20
US20120003295A1 (en) 2012-01-05
JP5014573B2 (ja) 2012-08-29
EP1549322A4 (de) 2006-07-26
JP2005538050A (ja) 2005-12-15
EP1549322B1 (de) 2010-02-17
US20060040891A1 (en) 2006-02-23
AU2003228966A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
ATE457733T1 (de) Lipid-a- und andere kohlenhydrat-liganden-analoga
TR200000815T2 (tr) In vitro hematopoietik hücrelerin stimulasyonu.
PT665886E (pt) Rearranjo de complexos de ciclina e suas utilizacoes
IL169896A0 (en) Methods and compositions for administering therapeutic and diagnostic agents
BRPI9912227B8 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
GB2458430A (en) Method for generating a reference signal sequence using grouping
MX2010004863A (es) Materiales y metodos para usarse en el procesamiento de biomasa.
MX2007007723A (es) Un biomaterial implantable y un metodo para producirlo.
WO2003029418A3 (en) Proliferation and differentiation of stem cells using extracellular matrix and other molecules
BR9712731A (pt) Fitase a partir de feijões de soja germinados
ATE447135T1 (de) Segment für einen sensorträgerkörper eines molches
BR0109062A (pt) Inibidores de frutose-1,6-bisfosfatase de arila
ATE213952T1 (de) Freisetzung und mobilisierung hämatopoietischer zellen
IL152111A0 (en) Tamandarin and didemnin analogs and methods of making and using them
GT200300046A (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso
GB2388190B (en) Methods for measuring enzyme activity
BRPI0417943A (pt) antagonistas de receptor de crf e métodos relacionados para essa finalidade
ATE497976T1 (de) Spezifisch an vygfvracl-hla-a24 bindende t-zellen-rezeptoren
EA200500005A1 (ru) Способ лечения повреждения, вызванного реперфузией после ишемии, с использованием антагонистов рецептора аденозина
WO2005033275A3 (en) Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration
AU2003288621A1 (en) Rna bioassay
NO20025738D0 (no) Metode
MX2007012954A (es) Sistemas de expresion en mamiferos.
WO2004016743A3 (en) Culturing anaplasma
MXPA06009711A (es) Uso de carboxipeptidasa g para combatir la toxicidad de antifolato.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1549322

Country of ref document: EP